Core Business and Dividend - Altria Group is recognized for its strong dividend history, boasting 56 consecutive years of dividend increases and a current yield of 7% as of December 8 [2][6] - The company has maintained a stable revenue stream despite declining smoking rates among American adults, which have dropped from approximately 42% in 1965 to just over 11% in 2022 [5][6] - Altria's pricing power has allowed it to offset declining volume, as consumers often continue purchasing preferred brands despite price increases [6][7] Financial Stability and Payout Ratios - Altria aims for a payout ratio of around 80% of its adjusted earnings per share (EPS), with recent payout ratios ranging from 70.8% to 82.9% [10] - The adjusted EPS provides a clearer picture of the company's operational earnings, indicating that the dividend is not in immediate jeopardy [9][10] - The stock is currently trading at about 10.7 times projected earnings for the next 12 months, suggesting it is undervalued compared to historical standards [11] Investment Perspective - While Altria may not offer high revenue growth, it is considered a solid option for investors seeking above-average dividend income [12] - The company is viewed as a bargain for those willing to invest despite concerns regarding the traditional cigarette business [11] - Altria's long-standing presence in the market and consistent dividend payments make it an attractive choice for income-focused investors [2][12]

Core Viewpoint - Altria Group announced the retirement of Chief Executive Billy Gifford, effective May, and appointed Chief Financial Officer Sal Mancuso as his successor [1] Company Summary - Billy Gifford will retire in May, marking a significant leadership change for Altria Group [1] - Sal Mancuso, currently the Chief Financial Officer, has been named as the new CEO [1]

Core Insights - Altria Group has performed well in 2025, with a stock increase of approximately 10% since January, or 16% including dividends [1] - The company is recognized as a Dividend King, boasting a dividend yield of 7.3% at its recent share price, which is a significant attraction for investors [2][8] - The sustainability of Altria's dividend is a concern for shareholders as the company faces slow growth in sales due to a shrinking customer base [2][5] Financial Performance - Altria's core cigarette business is declining, leading to limited top-line growth, which has resulted in a discounted stock price and higher dividend yield [6] - The company has a solid financial foundation, regularly increasing cigarette prices to counteract declining sales volumes, and is expected to grow earnings by 3% annually over the next three to five years [7] - The dividend payout ratio is 82% of 2025 earnings estimates, and Altria holds a multibillion-dollar stake in Anheuser-Busch InBev, providing liquidity options if necessary [8] Industry Trends - The tobacco industry is gradually shifting from traditional cigarettes to smoke-free products, such as electronic vapes and heat-not-burn devices [10] - Competitors like Philip Morris International and British American Tobacco have successfully integrated next-generation products into their portfolios, with these products accounting for 41% and 18.2% of their net sales, respectively [11] - Altria still heavily relies on cigarettes and cigars, which made up over 88% of its net revenue in the third quarter, indicating a potential risk of losing market share if it does not adapt to industry changes [12]

RICHMOND, Va.--(BUSINESS WIRE)---- $MO #Altria--Altria Declares Regular Quarterly Dividend of $1.06 Per Share. ...

Core Viewpoint - The Invesco High Dividend Low Volatility ETF (SPHD) offers a 4.71% yield, significantly higher than the S&P 500, by investing in a concentrated portfolio of 50 U.S. stocks known for high dividend yields and low volatility [2][3]. Group 1: ETF Overview - SPHD has $3.1 billion in assets and a low expense ratio of 0.30%, focusing on defensive sectors such as utilities, REITs, healthcare, and consumer staples [2][8]. - The fund's income is derived from dividends paid by the underlying companies, making the sustainability of these payouts crucial for investors [2]. Group 2: Top Holdings Analysis - The top five holdings in SPHD account for approximately 14% of the portfolio, emphasizing established dividend payers across various sectors [4]. - Pfizer (PFE) yields 6.53% with a conservative payout ratio of 36.4% and has a history of 19 consecutive years of dividend increases, despite recent revenue declines in COVID-related products [5]. - Altria (MO) offers a 7.04% yield with a payout ratio of 77.9%, maintaining a 19-year dividend growth streak, although it faces long-term risks from declining tobacco volumes [6]. - Healthpeak Properties (DOC) has the highest yield at 7.14%, but it shows negative GAAP earnings; it should be evaluated based on funds from operations, which are projected to be between $1.78 and $1.84 per share [7].

Valuation and Market Position - Altria Group, Inc. is trading at a forward 12-month price-to-earnings (P/E) ratio of 10.46, which is below the Tobacco industry's average of 13.89, the Consumer Staples sector's 16.02, and the S&P 500's 23.46, indicating an attractive valuation [1] - Compared to major peers, Altria remains discounted, with Philip Morris International Inc. at 18.12, Turning Point Brands, Inc. at 24.78, and British American Tobacco p.l.c. at 11.82 [1] Stock Performance - Over the past month, Altria's stock rose 1.1%, outperforming Turning Point Brands' 0.9% gain and Philip Morris' 3% decline, while British American Tobacco led with a 3.4% increase [6] - The Consumer Staples sector and the tobacco industry saw declines of 0.3% and 1.2%, respectively, while the S&P 500 gained 0.8%, highlighting Altria's strong positioning [7] Financial Fundamentals - In Q3 2025, Altria's adjusted earnings per share (EPS) increased by 3.6% to $1.45, with year-to-date EPS up 5.9%, driven by higher adjusted operating companies income (OCI) and a lower share count [11] - The smokeable products segment maintained impressive adjusted OCI margins of 64.4%, supported by effective pricing strategies [11] Product Strategy - Marlboro's premium-segment share expanded to 59.6%, reinforcing Altria's pricing power and brand strength, while the Basic brand gained share without detracting from Marlboro [12] - Altria's oral tobacco portfolio, particularly the on! brand, showed growth with a nearly 1% increase in volume and adjusted OCI margins expanding to 69.2% [13] Strategic Initiatives - Altria's collaboration with KT&G aims to enhance international modern oral expansion and explore operational efficiencies in traditional tobacco [14] - The company has consistently returned cash to shareholders, marking its 60th dividend increase in 56 years, which supports its stability and long-term growth [14] Volume Challenges - Altria faces significant volume pressures, with cigarette shipment volumes falling 8.2% in Q3 and 10.6% year-to-date, attributed to macroeconomic strains and competition from unregulated flavored disposable e-vapor products [15] Earnings Estimates - The Zacks Consensus Estimate for Altria's earnings has seen mixed revisions, with the 2025 EPS estimate increasing by 1 cent to $5.44, while the 2026 estimate decreased by 1 cent to $5.56 [18] - Altria is projected to deliver solid earnings growth of 6.3% in 2025 and 2.3% in 2026, despite modest adjustments [18]

Core Insights - Altria Group, Inc. experienced a paradox in its smokeable business during Q3 2025, with cigarette shipments declining while profitability increased [1] - The adjusted margin for the smokeable segment rose to 64.4%, indicating a consistent upward trend despite a 9% drop in domestic cigarette volumes [1][8] Pricing and Profitability - Price realization was the main driver of profitability, with higher list prices compensating for volume declines, leading to an adjusted operating income of $2,956 million for the quarter [2][8] - Marlboro's stability in the premium tier allowed Altria to increase its market share to 59.6%, a 0.3-point gain from the previous year [2] Margin Expansion Factors - Margin expansion was aided by lower per-unit settlement charges and effective control of operating expenses, which helped mitigate the impact of increased promotions and a shift towards discount brands [3] - Altria's data-driven pricing and product-mix strategies enabled the company to maintain strong profitability despite volume challenges [3][4] Competitive Landscape - Philip Morris International Inc. reported a 4.3% growth in combustible net revenue and a 7.7% increase in gross profit, despite a 3.2% decline in cigarette shipments, showcasing its pricing strength and market mix [5] - Turning Point Brands, Inc. saw a 39.7% year-over-year increase in gross profit, driven by significant growth in its Stoker's segment, indicating strong category fundamentals [6] Stock Performance and Valuation - Altria's shares increased by 0.7% over the past month, contrasting with a 1.6% decline in the industry [7] - The company trades at a forward price-to-earnings ratio of 10.44X, lower than the industry average of 13.83X, suggesting potential valuation attractiveness [10] Earnings Estimates - The Zacks Consensus Estimate for Altria's 2025 earnings per share has risen by 1 cent to $5.44, while the estimate for 2026 has decreased by 1 cent to $5.56 [11]

Summary of U.S. Consumer Strategy and Quantitative Research Call Industry Overview - The call focuses on the U.S. Consumer sector, specifically Consumer Discretionary and Consumer Staples, which have underperformed the market by low double-digit percentages year-to-date in 2025 [2][15]. Key Insights and Arguments 1. **Valuation Multiples**: Price to forward earnings valuation multiples for Consumer Staples appear attractive relative to the market, suggesting potential investment opportunities [2][15]. 2. **Market Dynamics**: The Consumer Staples and tech sectors are experiencing contrasting trading dynamics, with concerns about an AI bubble and its potential burst [3][16]. 3. **Economic Pressures**: Cutbacks in healthcare and SNAP benefits for low-income consumers, combined with rising inflation, may lead to an economic slowdown, while tax breaks for wealthier consumers in 2026 could sustain market strength [3][16]. 4. **Flight to Safety**: In the event of economic downturns, the Consumer Staples sector is expected to benefit from a flight to safety, particularly companies with a global presence [4][17][18]. 5. **Investment Recommendations**: Focus on higher-quality, defensive names with international exposure that are trading below historical averages. Specific sectors to watch include Soft Beverages, Household and Personal Care, and defensive Broadline Retailers [6][21]. Additional Important Points 1. **Key Themes and Catalysts**: - Tariff volatility affecting apparel and household products - GLP-1 drug uptake impacting consumer behavior - Bifurcation of consumer spending due to benefit cutbacks affecting lower-income households while higher-income households may benefit from tax breaks [5][20]. 2. **Subsector Focus**: - In Consumer Staples, companies with international exposure are preferred. - In Consumer Discretionary, names with reliable earnings performance are recommended, with caution advised for those lacking quality bias [6][21]. 3. **Upcoming Events**: Anticipated events such as the World Cup and U.S. 250th anniversary celebrations could provide additional support for certain sectors like Hotels, Resorts, and Cruise Lines [6][21]. Performance Ratings - Companies rated as Outperform include BRBR, CPB, MDLZ, MKC, and others, while CAG, GIS, HSY, and others are rated as Market-Perform. DECK and TGT are rated Underperform [9][10]. Conclusion - The U.S. Consumer sector is navigating a challenging landscape in 2025, with specific investment strategies recommended to capitalize on valuation opportunities and mitigate risks associated with economic pressures and consumer behavior shifts [12][19].

Altria looks attractive for investors who like a payout. ...

Core Viewpoint - Altria presents a high dividend yield of 7.2%, but the sustainability of the business supporting this dividend is questionable due to declining volumes in its primary smokable tobacco products [1][11]. Business Overview - Altria operates in the consumer staples sector, with smokable tobacco products accounting for 88% of its revenue [4]. - Unlike typical consumer staples, tobacco is not a necessity but relies on the addictive nature of nicotine to maintain customer loyalty [5]. Volume and Revenue Trends - The volume of Altria's smokable products has been in decline, with a reported drop of 8% in Q3 2025 and a 10.3% decline over the first nine months of the year [6]. - Revenue fell by 3% in Q3 2025 and approximately 3.4% for the first nine months, despite adjusted earnings rising by 3.6% and 5.9% respectively [7]. Pricing Strategy - The decline in volume has not led to a proportional revenue decline due to price increases, which have historically offset volume losses; however, this trend is now contributing to the volume problem [8]. Share Buybacks and Cost-Cutting - Altria's earnings growth has been supported by stock buybacks, with 1.9 million shares repurchased in Q3 2025, totaling 12.3 million shares for the first nine months [9]. - Cost-cutting measures have also contributed to maintaining the bottom line, but the overall business remains under significant pressure [10]. Future Outlook - The long-term outlook for Altria appears challenging, as the company is betting on management's ability to sustain the declining smokable tobacco business while developing new revenue streams [11]. - Previous attempts to diversify into vaping and marijuana have resulted in substantial financial losses, raising concerns about the risk-reward balance for investors [12].